H2AX and cancer: Such observations suggest that the application of γ-H2AX or other DNA repair biomarkers might be a useful “diagnostic” test to predict the response of cancer patient to radiotherapy and/or chemotherapy, leading to the development of “individualized therapy” for each patient.